Susquehanna International Group’s OptiNose OPTN Stock Holding History

Susquehanna International Group’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,967	Closed	-$54.6K	–	13216
2022 Q4	$54.6K	Buy	1,967 +14	+0.7%	+$532	﹤0.01%	11341
2022 Q3	$107K	Buy	+1,953	New	+$107K	﹤0.01%	11645
2022 Q1	–	Sell	-3,953	Closed	-$96K	–	13700
2021 Q4	$96K	Buy	+3,953	New	+$132K	﹤0.01%	12175

Susquehanna International Group's OPTN Position: Q2 2025 in Review

Susquehanna International Group sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 67,547 shares — an estimated $619K sold.

Susquehanna International Group first reported a position in OPTN in Q2 2019 and held it in 17 quarters. The position peaked at $619K in Q1 2025. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

Susquehanna International Group reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
Susquehanna International Group sold 67,547 OptiNose shares in Q2 2025, an estimated $619K.
Susquehanna International Group first reported a position in OptiNose in Q2 2019 and held it in 17 quarters.
Susquehanna International Group's OptiNose position peaked at $619K in Q1 2025.
0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.